Release Date: 13/07/16 09:29 Summary: ASX Listing Rules Waiver-BRB.AX Price Sensitive: No Download Document 47.58KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%